Author:
Tang Xiao-han,Deng Suo,Li Meng,Lu Mei-song
Funder
National Natural Science Foundation of China
National Natural Science Foundation of China (CN)
Publisher
Springer Science and Business Media LLC
Reference33 articles.
1. Li QQ, Lee RX, Liang H, Zhong Y, Reed E. Enhancement of cisplatin-induced apoptosis by beta-elemene in resistant human ovarian cancer cells. Med Oncol. 2013;30:424.
2. Wang B, Li S, Meng X, Shang H, Guan Y. Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells. Tumour Biol. 2015;36(8):6433–43.
3. Ishibashi M, Nakayama K, Yeasmin S, Katagiri A, Iida K, et al. A BTB/POZ gene, NAC-1, a tumor recurrence-associated gene, as a potential target for Taxol resistance in ovarian cancer. Clin Cancer Res. 2008;14:3149–55.
4. Miyamoto S, Yagi H, Yotsumoto F, Horiuchi S, Yoshizato T, et al. New approach to cancer therapy: heparin binding-epidermal growth factor-like growth factor as a novel targeting molecule. Anticancer Res. 2007;27:3713–21.
5. Song YD, Zhang KF, Liu D, Guo YQ, Wang DY, et al. Inhibition of EGFR-induced glucose metabolism sensitizes chondrosarcoma cells to cisplatin. Tumour Biol. 2014;35:7017–24.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献